Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
7.48
+0.01 (0.13%)
Feb 2, 2026, 1:39 PM EST - Market open

ARCT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2134608434509761,122
Market Cap Growth
-53.19%-45.45%87.08%-53.84%-13.03%581.69%
Enterprise Value
56252582307629835
Last Close Price
7.4716.9731.5316.9637.0143.38
PE Ratio
---48.17--
PS Ratio
2.083.025.052.1978.94117.59
PB Ratio
0.911.913.031.674.282.83
P/TBV Ratio
0.941.913.031.674.282.83
P/FCF Ratio
---18.56--
P/OCF Ratio
---14.08--
EV/Sales Ratio
0.581.653.491.4950.8987.55
EV/EBITDA Ratio
---22.44--
EV/EBIT Ratio
---25.25--
EV/FCF Ratio
---12.67--
Debt / Equity Ratio
0.120.120.110.350.300.05
Debt / EBITDA Ratio
---5.15--
Debt / FCF Ratio
---3.91--
Asset Turnover
0.300.390.380.490.030.03
Quick Ratio
5.943.683.953.113.769.39
Current Ratio
7.864.674.723.183.819.45
Return on Equity (ROE)
-27.43%-31.16%-10.83%3.75%-65.20%-34.16%
Return on Assets (ROA)
-15.00%-15.46%-11.11%1.80%-29.17%-16.00%
Return on Invested Capital (ROIC)
-118.94%-388.71%----
Return on Capital Employed (ROCE)
-31.30%-34.30%-22.50%3.80%-69.20%-16.80%
Earnings Yield
-31.64%-17.61%-3.53%2.08%-20.88%-6.43%
FCF Yield
-27.82%-13.14%-2.49%5.39%-14.19%-3.98%
Buyback Yield / Dilution
-0.72%-1.40%1.72%-2.95%-29.61%-68.24%
Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q